Literature DB >> 17931794

Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer.

Hans Paul van der Laan1, Alphons van den Bergh, Cornelis Schilstra, Renske Vlasman, Harm Meertens, Johannes A Langendijk.   

Abstract

PURPOSE: To assess the association between the dose distributions in the rectum and late Radiation Therapy Oncology Group and the European Organisation for Research and Treatment of Cancer (RTOG/EORTC), Late Effects of Normal Tissue SOMA, and Common Terminology Criteria for Adverse Events (CTCAE) version 3.0 graded rectal toxicity among patients with prostate cancer treated with RT. METHODS AND MATERIALS: Included in the study were 124 patients who received three-dimensional conformal RT for prostate cancer to a total dose of 70 Gy in 2-Gy fractions. All patients completed questionnaires regarding rectum complaints before RT and during long-term follow-up. Late rectum Grade 2 or worse toxicity, according to RTOG/EORTC, LENT SOMA, and CTCAE v3.0 criteria, was analyzed in relation to rectal dose and volume parameters.
RESULTS: Dose-volume thresholds (V40>or=65%, V50>or=55%, V65>or=45%, V70>or=20%, and a rectum volume<or=140 cm3), significantly discriminated patients with late Grade 0-1 and Grade 2 or worse rectal toxicity, particularly using the LENT SOMA and CTCAE v3.0 systems. The rectum volume receiving>or=70 Gy (V70) was most predictive for late Grade 2 or worse rectal toxicity with each of the grading systems. The associations were strongest, however, with use of the LENT SOMA system.
CONCLUSIONS: Volume effects for late radiation-induced rectal toxicity are present, but their clinical significance depends on the grading system used. This should be taken into account in the interpretation of studies reporting on radiation-induced rectal toxicity.

Entities:  

Mesh:

Year:  2007        PMID: 17931794     DOI: 10.1016/j.ijrobp.2007.07.2363

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

1.  Analyzing the Usage of Standards in Radiation Therapy Clinical Studies.

Authors:  Y Zhen; Y Jiang; L Yuan; J Kirkpartrick; J Wu; Y Ge
Journal:  IEEE EMBS Int Conf Biomed Health Inform       Date:  2017-04-13

2.  Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?

Authors:  Mirko Nitsche; Werner Brannath; Matthias Brückner; Dirk Wagner; Alexander Kaltenborn; Nils Temme; Robert M Hermann
Journal:  Br J Radiol       Date:  2016-12-12       Impact factor: 3.039

3.  Hydrogel Spacer Reduces Rectal Dose during Proton Therapy for Prostate Cancer: A Dosimetric Analysis.

Authors:  Praveen Polamraju; Alexander F Bagley; Tyler Williamson; X Ronald Zhu; Steven J Frank
Journal:  Int J Part Ther       Date:  2019-05-01

Review 4.  Reducing rectal injury in men receiving prostate cancer radiation therapy: current perspectives.

Authors:  Nicholas A Serrano; Noah S Kalman; Mitchell S Anscher
Journal:  Cancer Manag Res       Date:  2017-07-28       Impact factor: 3.989

5.  Self-assessed bowel toxicity after external beam radiotherapy for prostate cancer--predictive factors on irritative symptoms, incontinence and rectal bleeding.

Authors:  Michael Pinkawa; Marc D Piroth; Karin Fischedick; Sandra Nussen; Jens Klotz; Richard Holy; Michael J Eble
Journal:  Radiat Oncol       Date:  2009-09-21       Impact factor: 3.481

6.  Late gastrointestinal toxicity after dose-escalated conformal radiotherapy for early prostate cancer: results from the UK Medical Research Council RT01 trial (ISRCTN47772397).

Authors:  Isabel Syndikus; Rachel C Morgan; Matthew R Sydes; John D Graham; David P Dearnaley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-10-14       Impact factor: 7.038

7.  Structured gastroenterological intervention and improved outcome for patients with chronic gastrointestinal symptoms following pelvic radiotherapy.

Authors:  Caroline C Henson; Susan E Davidson; Yeng Ang; Chris Babbs; John Crampton; Mark Kelly; Simon Lal; Jimmy K Limdi; Greg Whatley; Ric Swindell; Wendy Makin; John McLaughlin
Journal:  Support Care Cancer       Date:  2013-03-21       Impact factor: 3.603

8.  Toxicity and Long-Term Outcomes of Dose-Escalated Intensity Modulated Radiation Therapy to 74Gy for Localised Prostate Cancer in a Single Australian Centre.

Authors:  Joseph Sia; Daryl Lim Joon; Angela Viotto; Carmel Mantle; George Quong; Aldo Rolfo; Morikatsu Wada; Nigel Anderson; Maureen Rolfo; Vincent Khoo
Journal:  Cancers (Basel)       Date:  2011-09-01       Impact factor: 6.639

9.  Development of a prediction model for late urinary incontinence, hematuria, pain and voiding frequency among irradiated prostate cancer patients.

Authors:  Wouter Schaake; Arjen van der Schaaf; Lisanne V van Dijk; Alfons C M van den Bergh; Johannes A Langendijk
Journal:  PLoS One       Date:  2018-07-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.